Aging and Neurodegeneration
- Age-related Cognitive Decline
- Neurodegenerative Diseases of the Elderly
- Alzheimer’s Disease and Dementia Research
- Parkinson’s Disease and Movement Disorders
- Age-Related Changes in Brain Structure and Function
- Neuroplasticity Across the Lifespan
Aging and Neurodegeneration are major challenges in neurology and neuroscience, with rising global life expectancy increasing the prevalence of neurodegenerative diseases. This session will explore the biological mechanisms underlying brain aging, neuroinflammation, oxidative stress, mitochondrial dysfunction, protein misfolding, and synaptic decline, which contribute to disorders such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Huntington’s disease. Advances in genomics, epigenetics, and biomarker discovery are shedding light on early detection strategies and risk assessment for age-related neurodegenerative diseases.
Key discussions will focus on therapeutic interventions, including neuroprotective drugs, gene therapy, stem cell-based approaches, lifestyle modifications, and precision medicine to slow disease progression and enhance cognitive function. Emerging research on the gut-brain axis, neurovascular health, metabolic factors, and the role of exercise, diet, and cognitive training in promoting healthy brain aging will also be highlighted. Additionally, experts will discuss advancements in AI-driven diagnostics, neuroimaging, and clinical trials aimed at improving treatment outcomes. By bringing together leading neurologists, neuroscientists, geriatricians, and researchers, this session will foster collaboration to address the growing burden of neurodegenerative diseases and develop innovative strategies for maintaining brain health in aging populations.
